Press Release
Fieldfisher advises on over US$1 billion of metals and mining deals
Firm strengthens reputation as leading adviser to growing international mining and metals companies, successfully closing a string of major strategic financing and broader corporate deals in testing market conditions.
Press Release
Fieldfisher clients awarded over £3 million costs in LCIA arbitration
Team led by partner Simon Sloane secured award for Littop Enterprises, Bridgemont Ventures and Bordo Management in an LCIA arbitration against Ukraine's Naftogaz.
Press Release
Fieldfisher successfully overturns $ 2.6 billion Worldwide Freezing Order
Fieldfisher has successfully set aside a $2.6 billion Worldwide Freezing Order (WFO) on behalf of its client Mr Igor Kolomoisky and had the case against him struck out
Press Release
Fieldfisher has expanded its Chinese operation with a new office in Guangzhou
Fieldfisher has expanded in China with a new office in Guangzhou and the hiring of three partners and four associates
Press Release
Fieldfisher breaks through £200m for financial year 2017-2018
International law firm Fieldfisher has announced a 24 per cent increase in annual turnover to £207 million
Press Release
Fieldfisher team achieves a total victory for the liquidators of Goldtrail Travel
A Fieldfisher team of Kit Jarvis, Tracey Wright and Galina Borshevskaya have achieved a total victory for the liquidators of Goldtrail Travel, PricewaterhouseCoopers ("PwC"). The judgement handed down by the Court of Appeal has effectively brought to an end the long running claim made by the liquidators of Goldtrail Travel – PwC – against Turkish airline Onur Air.
Press Release
Press Release
The Criminal Finances Act to come into force targeting tax evasion
UK companies could be liable for prosecution and unlimited fines when one of the strictest and most wide ranging pieces of tax legislation becomes law.
Press Release
Fieldfisher advises administrators of listed pharma company on ground-breaking IP disposal
Our team led advised joint administrators of Redx Pharma plc on the disposal of assets, including patents in the Redx BTK program, for the sum of US$40 million.
